Phibro Animal Health Corp (NASDAQ:PAHC) Receives $26.60 Average Target Price from Brokerages

Phibro Animal Health Corp (NASDAQ:PAHC) has received a consensus rating of “Hold” from the ten analysts that are currently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating on the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $26.60.

A number of analysts recently commented on PAHC shares. TheStreet lowered Phibro Animal Health from a “b-” rating to a “c+” rating in a research report on Tuesday, September 10th. Barclays decreased their target price on Phibro Animal Health from $25.00 to $18.00 and set an “underweight” rating for the company in a research report on Thursday, August 29th. ValuEngine raised Phibro Animal Health from a “sell” rating to a “hold” rating in a research report on Wednesday, October 2nd. BidaskClub lowered Phibro Animal Health from a “buy” rating to a “hold” rating in a research report on Friday, August 30th. Finally, Morgan Stanley raised Phibro Animal Health from an “underweight” rating to an “equal” rating and boosted their target price for the company from $21.00 to $30.00 in a research report on Thursday, September 5th. They noted that the move was a valuation call.

In other news, Director E Thomas Corcoran bought 5,000 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The stock was acquired at an average cost of $21.21 per share, with a total value of $106,050.00. Following the transaction, the director now directly owns 15,000 shares of the company’s stock, valued at approximately $318,150. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 50.05% of the company’s stock.

A number of hedge funds have recently added to or reduced their stakes in the business. FNY Investment Advisers LLC boosted its stake in Phibro Animal Health by 73.3% during the 2nd quarter. FNY Investment Advisers LLC now owns 1,040 shares of the company’s stock valued at $33,000 after purchasing an additional 440 shares during the last quarter. Aperio Group LLC boosted its stake in shares of Phibro Animal Health by 3.5% in the 2nd quarter. Aperio Group LLC now owns 14,585 shares of the company’s stock worth $463,000 after buying an additional 500 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Phibro Animal Health by 74.5% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,361 shares of the company’s stock worth $29,000 after buying an additional 581 shares during the last quarter. Marshall Wace North America L.P. boosted its stake in shares of Phibro Animal Health by 12.4% in the 2nd quarter. Marshall Wace North America L.P. now owns 7,119 shares of the company’s stock worth $226,000 after buying an additional 786 shares during the last quarter. Finally, Swiss National Bank boosted its stake in shares of Phibro Animal Health by 2.4% in the 2nd quarter. Swiss National Bank now owns 37,800 shares of the company’s stock worth $1,201,000 after buying an additional 900 shares during the last quarter. Institutional investors and hedge funds own 51.74% of the company’s stock.

Shares of PAHC stock traded down $0.35 during mid-day trading on Monday, hitting $21.09. The company’s stock had a trading volume of 192,411 shares, compared to its average volume of 208,793. The company’s fifty day simple moving average is $21.30 and its 200-day simple moving average is $28.65. Phibro Animal Health has a 52 week low of $20.00 and a 52 week high of $44.99. The company has a debt-to-equity ratio of 1.45, a quick ratio of 1.74 and a current ratio of 3.02. The company has a market cap of $867.31 million, a PE ratio of 14.10, a P/E/G ratio of 4.30 and a beta of 0.88.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings data on Tuesday, August 27th. The company reported $0.33 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.34 by ($0.01). Phibro Animal Health had a return on equity of 29.99% and a net margin of 6.59%. The business had revenue of $203.90 million during the quarter, compared to the consensus estimate of $206.00 million. During the same period last year, the business posted $0.46 earnings per share. The business’s revenue was down 3.7% on a year-over-year basis. On average, equities analysts anticipate that Phibro Animal Health will post 1.12 earnings per share for the current year.

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Wednesday, September 4th were given a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 2.28%. The ex-dividend date was Tuesday, September 3rd. Phibro Animal Health’s payout ratio is 31.37%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Featured Story: What member countries make up the G-20?

Analyst Recommendations for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.